Show simple item record

dc.creatorHungria, Vania
dc.creatorGarnica, Marcia
dc.creatorQueiroz Crusoé, Edvan de
dc.creatorPessoa de Magalhaes Filho, Roberto Jose
dc.creatorMartinez, Gracia
dc.creatorBittencourt, Rosane
dc.creatorCordeiro de Farias, Danielle Leão
dc.creatorBraga, Walter Moises
dc.creatorPinto Neto, Jorge Vaz
dc.creatorNogueira Ribeiro, Glaciano
dc.creatorMaiolino, Angelo
dc.date.accessioned2020-10-01T16:04:04Z
dc.date.available2020-10-01T16:04:04Z
dc.date.created2020
dc.identifier.issn2531-1379spa
dc.identifier.otherhttps://doi.org/10.1016/j.htct.2020.05.001spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/14088
dc.description.abstractSince the World has been facing the COVID-19 pandemic, special attention has been taken concerning cancer patients; related to their immunosuppression status, adding risk for more aggressive COVID-19 and mortality, but also concerns about the access and the quality of care in cancer therapy. The COVID-19 pandemic impacts the number of infected, its related mortality, as well as the care of cancer patients. Multiple myeloma patients are a particular group with several important aspects to be considered during pandemic times. In essence, they are immunosuppressed in differentintensities during their treatment. Most ofthem are elderly and all of them require long-term therapy, with prolonged contact with the health care system, possibly including a stem cell transplant during the treatment. A panel of experts in multiple myeloma and infectious diseases discusses pieces of evidence and the lack of the same in the scenario of COVID-19 in myeloma patients, while also exposing what is expected for the next phases of the COVID-19 pandemic.spa
dc.format.extent6 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherHematology, Transfusion and Cell Therapyspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCOVID-19spa
dc.subjectSARS-CoV-2spa
dc.subjectMultiple myelomaspa
dc.titleManaging patients with multiple myeloma during the COVID-19 pandemic: recommendations from an expert panel – ABHH monoclonal gammopathies committespa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAbierto (Texto Completo)spa
dc.identifier.doihttps://doi.org/10.1016/j.htct.2020.05.001spa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record